-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

624.O2.6 624. Hodgkin Lymphoma and T/NK Cell Lymphoma—Clinical Studies: Clinical Studies in Hodgkin Lymphoma Clinically Relevant Abstract

Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Biological, Adult, antibodies, Diseases, Non-Biological, Therapies, Hodgkin Lymphoma, Combinations, checkpoint inhibitors, Adverse Events, chemotherapy, enzyme inhibitors, T-Cell Lymphoma, immunotherapy, Study Population, Lymphoid Malignancies, Clinically relevant, transplantation
Sunday, December 6, 2020: 2:00 PM-3:30 PM
Moderators:
Patrick B. Johnston, MD/ PhD, Mayo Clinic and Ann S. LaCasce, MD, MSc, Dana-Farber Cancer Inst.
Disclosures:
No relevant conflicts of interest to declare.
2:00 PM

Alison J. Moskowitz, MD1, Gunjan Shah, MD2*, Heiko Schöder, MD1*, Nivetha Ganesan, MPH1*, Helen Hancock, ANP1*, Theresa Davey, MMSc, PA-C1*, Samia Sohail, BA1*, Alayna Santarosa1*, Lauren Pomerantz, BS1*, Christine Jarjies, MS1*, Natasha Galasso, BA1*, Rachel Neuman1*, Anita Kumar, MD1, Oscar B Lahoud, MD3, Connie Lee Batlevi, MD, PhD1, Paul A. Hamlin, MD1, David J. Straus, MD1, Ildefonso Rodriguez-Rivera, MD1*, Colette Owens, MD1, Philip Caron, MD, PhD1, Andrew M. Intlekofer, MD, PhD1, Audrey Hamilton, MD1*, Steven M. Horwitz, MD1, Lorenzo Falchi, MD1, Erel Joffe, MD, MSc1, Maria Lia Palomba1, Ariela Noy, MD4, Matthew J Matasar, MD, MS5, Georgios Pongas, MD6, Santosha Vardhana, MD, PhD1*, Gottfried R. von Keudell, MD, PhD1, Joachim Yahalom, MD1, Andrew D Zelenetz, MD, PhD1 and Craig H. Moskowitz, MD6

1Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY
2Department of Medicine, Adult Bone Marrow Transplant Service, Memorial Sloan Kettering Cancer Center, New York, NY
3Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, Brooklyn, NY
4Department of Medicine, Lymphoma Service, Memorial Sloan-Kettering Cancer Ctr., New York, NY
5Department of Medicine, Lymphoma Service, Memorial Sloan-Kettering Cancer Center/New York Presbyterian, New York, NY
6Sylvester Comprehensive Cancer Center, University of Miami Health System, Miami, FL

2:15 PM

Christopher A. Yasenchak, MD1, Rodolfo Bordoni, MD2*, Dipti Patel-Donnelly, MD3, Timothy Larson, MD4*, Jerome Goldschmidt, MD5*, Ralph V. Boccia, MD6, Vivian J.M. Cline7*, Mariana Sacchi, MD8*, Andres Forero-Torres9*, Robert B. Sims, MD9, Jingmin Liu9* and Jonathan W. Friedberg, MD, MSSc10

1Willamette Valley Cancer Institute and Research Center, Eugene, OR
2Georgia Cancer Specialists, Marietta, GA
3Virginia Cancer Specialists, Fairfax, VA
4Minnesota Oncology P.A., Minneapolis, MN
5Oncology and Hematology Associates of SW Virginia, Blackburgs, VA
6Center for Cancer and Blood Disorders, Bethesda, MD
7U.S. Oncology Associates, Austin, TX
8Bristol-Myers Squibb Company, Princeton, NJ
9Seattle Genetics, Inc., Bothell, WA
10University of Rochester Medical Center, Rochester, NY

2:30 PM

Alex F. Herrera, MD1, Lu Chen, PhD2*, Yago Nieto, MD3, Leona Holmberg, MD, PhD4*, Patrick B. Johnston, MD/ PhD5, Matthew Mei, MD6, Leslie Popplewell, MD1*, Saro H. Armenian, DO, MPH7, Thai Cao, MD8*, Len Farol, MD9*, Firoozeh Sahebi, MD10, Ricardo Spielberger, MD9*, Robert Chen, MD11, Auayporn P. Nademanee, MD, BS12, Lacolle Peters1*, Neena Kennedy1*, Steven T. Rosen, MD13, Larry W. Kwak, MD, PhD14, Stephen J. Forman, MD15 and Tatyana A. Feldman, MD16

1City of Hope, Duarte, CA
2Department of Information Sciences, City of Hope, Duarte
3Department of Stem Cell Transplantation and Cellular Therapy, UT M.D. Anderson Cancer Ctr., Houston, TX
4Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA
5Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN
6Gehr Family Center for Leukemia Research, City of Hope Medical Center, Duarte, CA
7Department of Population Sciences, City of Hope, Duarte, CA
8Department of Hematology/HCT, City of Hope National Medical Center, Duarte, CA
9Gehr Family Center for Leukemia Research, City of Hope, Duarte, CA
10Judy and Bernard Briskin Center for Multiple Myeloma Research, City of Hope, Duarte, CA
11Autolus Limited, London, United Kingdom
12Department of Hematology/HCT, City of Hope Nat'l. Med. Ctr., Duarte, CA
13Beckman Research Institute, City of Hope, Duarte, CA
14Deputy Director, City of Hope Comprehensive Cancer Center, Duarte, CA
15Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, CA
16Hackensack University Medical Center, NY, NY

2:45 PM

Jakub Svoboda, MD, Stefan K. Barta, MD, MRCP, MS, Daniel J. Landsburg, MD, Sunita Dwivedy Nasta, MD, Wei-Ting Hwang, PhD*, Grace Delp*, Brittany Amundsen*, Hatcher J. Ballard, BS*, James N. Gerson, MD, Elise A. Chong, MD, Mitchell E. Hughes, PharmD*, Steven A. Emanuel*, Marco Ruella, MD and Stephen J. Schuster, MD

Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA

3:00 PM

Alex F. Herrera, MD1, Carmelo Carlo-Stella, MD2, Graham P. Collins, MD, DPhil3, Kami J. Maddocks, MD4, Nancy L. Bartlett, MD5*, Kerry J. Savage, MD MSc6, Paolo F Caimi7*, Brian T. Hess, MD8, Pier Luigi Zinzani, MD9, Hans G Cruz10, Luqiang Wang11*, Jay Feingold12*, Jens Wuerthner10* and Stephen M. Ansell, MD, PhD13

1Department of Hematology and Hematopoietic Cell Transplantation, City of Hope Comprehensive Cancer Center, Duarte, CA
2Department of Oncology and Hematology, Humanitas Cancer Center, Humanitas University, Milan, Italy
3Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom
4Division of Hematology, Department of Internal Medicine, Ohio State University Hospital, Columbus, OH
5Division of Oncology, Washington University School of Medicine in St Louis, St. Louis, MO
6Department of Medical Oncology, BC Cancer and University of British Columbia, Vancouver, BC, Canada
7University Hospitals Cleveland Medical Center/Case Western Reserve University, Cleveland, OH
8Division of Hematology and Medical Oncology, Department of Medicine, Medical University of South Carolina, Charleston, SC
9Institute of Hematology "Seràgnoli" University of Bologna, Bologna, Italy
10Clinical Development, ADC Therapeutics SA, Epalinges, Switzerland
11ADC Therapeutics America, Inc., Murray Hill, NJ
12ADC Therapeutics America, Inc, Murray Hill, NJ
13Mayo Clinic, Rochester, MN

3:15 PM

Olivier Casasnovas, MD1*, Judith Racape, MD2*, Julie Dechene3*, Reda Bouabdallah, MD4*, Pauline Brice, MD5*, Julien Lazarovici, MD6*, Hervé Ghesquieres, MD, PhD7*, Aspasia Stamatoulas Bastard, MD8*, Jehan Dupuis, MD9*, Anne-Claire Gac, MD10*, Thomas Gastinne, MD11*, Bertrand Joly, MD12*, Krimo Bouabdallah, MD13*, Emmanuelle Nicolas-Virelizier, MD14*, Pierre Feugier, MD15*, Franck Morschhauser, MD, PhD16,17*, Marc André, MD18*, Alina Berriolo-Riedinger, MD19*, Veronique Edeline, MD20*, Clémentine Joubert, PhD21*, Michel Meignan, MD22* and Isabelle Demeestere, MD23*

1Hematology Department, University Hospital F. Mitterrand and Inserm UMR 1231, Dijon, France
2Research Center in Epidemiology, School of public Health, and Biomedical Research Department, CUB-Erasme Université Libre de Bruxelles, Brussels, Belgium
3Research Laboratory on Human Reproduction, Université Libre de Bruxelles, Brussels, Belgium
4Institut Paoli-Calmettes, Marseille, France
5Department of Hematology, APHP, Hopital Saint Louis, Paris, France
6Department of hematology, Gustave Roussy Cancer Campus Grand Paris, Villejuif CEDEX, France
7Department of Hematology, Centre Hospitalier Lyon Sud, Hospices Civils de Lyon, Pierre Benite, France
8Department of Hematology, Centre Henri Becquerel, Rouen, France
9Lymphoid Malignancies, Henri Mondor Hospital, Creteil, France
10Institut d'Hématologie de Basse-Normandie, CHU de Caen Normandie, Caen, France
11Clinical Hematology, Nantes University Hospital, Nantes, France
12Department of hematology, CH Sud Francilien, Corbeil Essonnes, FRA
13Department of Hematology, University Hospital of Bordeaux, Pessac, France
14Hematology, Centre Leon Berard, Lyon, France
15Department of Hematology, Henri Poincaré University, CHU NANCY BRABOIS, Vandoeuvre Les Nancy, France
16Department of Hematology, University Lille, CHU Lille, EA 7365 - GRITA - Groupe de Recherche sur les forms Injectables et les Technologies Associées, Lille, France
17Clinical Hematology Department, Centre Hospitalier Régional Universitaire de Lille, Lille, France
18Department of Hematology, CHU UCL Namur - Site Godinne, Yvoir, Belgium
19Department of Nuclear Medicine, Centre Georges Francois Leclerc, University of Dijon, Dijon, France
20Service de Médecine Nucléaire, Hopital Rene Huguenin-Institut Curie, Saint Cloud, France
21Lymphoma Academic Research Organization, Lyon, France
22LYSA, Paris, France
23Fertility Clinic, CUB-Erasme Hospital, and Research Laboratory on Human Reproduction, Université Libre de Bruxelles, Brussels, Belgium

*signifies non-member of ASH